+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Joint Pain Injections Global Market Report 2024

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • The Business Research Company
  • ID: 5752133
Joint pain injections serve to reduce inflammation and discomfort, typically administered directly into the joint to alleviate pain. Joint pain is a common occurrence, particularly among the elderly or individuals with pre-existing medical conditions or disorders. Conditions such as arthritis, characterized by pain and inflammation, often contribute to joint pain. Joint pain injections offer a non-surgical approach to quickly relieve joint pain and inflammation.

The primary types of injections for joint pain include steroid joint injections, hyaluronic acid injections, platelet-rich plasma (PRP) injections, placental tissue matrix (PTM) injections, and various others. Steroid joint injections, also known as corticosteroid injections, are anti-inflammatory medications used to treat joint pain. They are particularly effective in reducing inflammation in individuals with conditions like rheumatoid arthritis and other forms of inflammatory arthritis. Joint pain injections are applied to various types of joints, including the hip joint, knee and ankle joints, shoulder and elbow joints, facet joints of the spine, and others. These injections are commonly distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The joint pain injections market research report is one of a series of new reports that provides joint pain injections market statistics, including joint pain injections industry global market size, regional shares, competitors with a joint pain injections market share, detailed joint pain injections market segments, market trends and opportunities, and any further data you may need to thrive in the joint pain injections industry. This joint pain injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The joint pain injections market size has grown rapidly in recent years. It will grow from $5.19 billion in 2023 to $5.75 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth observed in the historical period can be attributed to factors such as an increased aging population, a prevalence of arthritis, global health initiatives, the digitalization of healthcare, and a growing awareness of chronic pain management.

The joint pain injections market size is expected to see rapid growth in the next few years. It will grow to $8.8 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The projected growth in the forecast period can be linked to the expansion of telehealth services, the development of personalized pain management approaches, increased focus on patient education and empowerment, the adoption of sustainable healthcare practices, and the integration of nutritional support. Key trends expected in the forecast period involve advancements in regenerative medicine, further developments in personalized pain management, innovation in injection materials, the incorporation of rehabilitation technologies, and the use of artificial intelligence (AI) to enhance injections.

The joint pain injections market is poised for growth due to the increasing prevalence of arthritis and musculoskeletal disorders. Musculoskeletal disorders rank as the leading cause of disability globally, with low back pain standing out as the primary cause of impairment in 160 nations. Patients seek pain relief and address inflammatory conditions through injections. According to a report by the World Health Organization (WHO) in February 2021, approximately 1.71 billion people worldwide are affected by musculoskeletal conditions, a number continually rising due to population growth and aging. Similarly, arthritis, affecting around 350 million people globally and rapidly increasing, contributes to the upward trajectory of the joint pain injections market.

The growth of the joint pain injections market is expected to be propelled by the increase in the incidence of chronic pain. Chronic pain, persisting for an extended period, is a prevalent issue affecting millions globally. Joint pain injections play a crucial role in managing chronic pain, especially when associated with musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, or other joint-related problems. As highlighted by the World Health Organization (WHO) in September 2022, chronic diseases, including those causing chronic pain, account for a significant percentage of global deaths. The escalating incidence of chronic pain is, therefore, a driving force behind the growth of the joint pain injections market.

A prominent trend in the joint pain injections market is the focus on new product development. Major companies in this sector are actively engaged in innovating new products to meet consumer demand and enhance their market position. For instance, Contura International Ltd., a UK-based manufacturer of therapeutic hydrogels, introduced Arthrosamid in September 2021. Arthrosamid, an innovative hydrogel injection for knee osteoarthritis, utilizes non-biodegradable hydrogel technology, providing a potent, long-lasting, secure, and minimally intrusive treatment for knee osteoarthritis pain.

Major companies in the joint pain injections market are introducing new products to augment their market presence. In May 2021, Ono Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company, launched JOYCLU 30mg Intra-articular Injection, aimed at improving joint function. The injection is designed for the treatment of knee and hip osteoarthritis, combining hyaluronic acid and the anti-inflammatory medication diclofenac through a patented Seikagaku technique.

In October 2021, Pacira BioSciences, a US-based company specializing in non-opioid pain management, acquired Flexion Therapeutics for $630 million. This acquisition strengthens patient access to Zilretta, Flexion Therapeutics' principal product - a non-opioid injection for pain treatment. Zilretta is the only FDA-approved injection for intra-articular therapy in patients facing osteoarthritis-related knee pain. The acquisition also provides Pacira access to Flexion's medication candidates, FX201 and FX301, further expanding its portfolio in musculoskeletal disorder treatment.

Major companies operating in the joint pain injections market include Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., Abbvie Inc., Bioventus Inc., Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Ltd., Merck & Co. Inc., GlaxoSmithKline PLC, Novartis AG, AstraZeneca PLC, Roche Holding AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Bayer AG, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen SA, Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Zydus Lifesciences Limited

North America was the largest region in the joint pain injections market in 2023. The regions covered in the joint pain injections market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the joint pain injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The joint pain injections market consists of sales of epidural steroid injections, facet joint injections, viscosupplementation injections, corticosteroid injections and hyaluronic acid injections. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Joint Pain Injections Market Characteristics3. Joint Pain Injections Market Trends And Strategies
4. Joint Pain Injections Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Joint Pain Injections Market Size and Growth
5.1. Global Joint Pain Injections Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Joint Pain Injections Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Joint Pain Injections Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Joint Pain Injections Market Segmentation
6.1. Global Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Steroid Joint Injection
Hyaluronic Acid Injections
Platelet-Rich Plasma (PRP) Injections
Placental Tissue Matrix (PTM) Injections
Other Type Of Injection
6.2. Global Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hip Joint
Knee And Ankle
Shoulder And Elbow
Facet Joints Of The Spine
Other Joint Types
6.3. Global Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
7. Joint Pain Injections Market Regional And Country Analysis
7.1. Global Joint Pain Injections Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Joint Pain Injections Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Joint Pain Injections Market
8.1. Asia-Pacific Joint Pain Injections Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Joint Pain Injections Market
9.1. China Joint Pain Injections Market Overview
9.2. China Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Joint Pain Injections Market
10.1. India Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Joint Pain Injections Market
11.1. Japan Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Joint Pain Injections Market
12.1. Australia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Joint Pain Injections Market
13.1. Indonesia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Joint Pain Injections Market
14.1. South Korea Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Joint Pain Injections Market
15.1. Western Europe Joint Pain Injections Market Overview
15.2. Western Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Joint Pain Injections Market
16.1. UK Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Joint Pain Injections Market
17.1. Germany Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Joint Pain Injections Market
18.5. France Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Joint Pain Injections Market
19.9. Italy Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Joint Pain Injections Market
20.13. Spain Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Joint Pain Injections Market
21.1. Eastern Europe Joint Pain Injections Market Overview
21.2. Eastern Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Joint Pain Injections Market
22.1. Russia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Joint Pain Injections Market
23.1. North America Joint Pain Injections Market Overview
23.2. North America Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Joint Pain Injections Market
24.1. USA Joint Pain Injections Market Overview
24.2. USA Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Joint Pain Injections Market
25.1. Canada Joint Pain Injections Market Overview
25.2. Canada Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Joint Pain Injections Market
26.1. South America Joint Pain Injections Market Overview
26.2. South America Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Joint Pain Injections Market
27.1. Brazil Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Joint Pain Injections Market
28.1. Middle East Joint Pain Injections Market Overview
28.2. Middle East Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Joint Pain Injections Market
29.1. Africa Joint Pain Injections Market Overview
29.2. Africa Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Joint Pain Injections Market Competitive Landscape And Company Profiles
30.1. Joint Pain Injections Market Competitive Landscape
30.2. Joint Pain Injections Market Company Profiles
30.2.1. Seikagaku Corporation
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Flexion Therapeutics Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Zimmer Biomet Holdings Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Sanofi S.A.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Anika Therapeutics Inc
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Global Joint Pain Injections Market Competitive Benchmarking32. Global Joint Pain Injections Market Competitive Dashboard33. Key Mergers And Acquisitions In The Joint Pain Injections Market
34. Joint Pain Injections Market Future Outlook and Potential Analysis
34.1 Joint Pain Injections Market In 2028 - Countries Offering Most New Opportunities
34.2 Joint Pain Injections Market In 2028 - Segments Offering Most New Opportunities
34.3 Joint Pain Injections Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

Executive Summary

Joint Pain Injections Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on joint pain injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for joint pain injections? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

  • Markets Covered: 1) By Type Of Injection: Steroid Joint Injection; Hyaluronic Acid Injections; Platelet-Rich Plasma (PRP) Injections; Placental Tissue Matrix (PTM) Injections; Other Type Of Injections 2) By Joint Type: Hip Joint; Knee And Ankle; Shoulder And Elbow; Facet Joints Of The Spine; Other Joint Types 3) By Distribution channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Companies Mentioned: Seikagaku Corporation; Flexion Therapeutics Inc.; Zimmer Biomet Holdings Inc.; Sanofi S.A.; Anika Therapeutics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Seikagaku Corporation
  • Flexion Therapeutics Inc.
  • Zimmer Biomet Holdings Inc.
  • Sanofi S.A.
  • Anika Therapeutics Inc.
  • Abbvie Inc.
  • Bioventus Inc.
  • Eli Lilly and Company
  • Ferring Pharmaceuticals Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Limited
  • Johnson & Johnson Services Ltd.
  • Merck & Co. Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • AstraZeneca plc
  • Roche Holding AG
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim International GmbH
  • Takeda Pharmaceutical Company Limited
  • Bayer AG
  • Astellas Pharma Inc.
  • Daiichi Sankyo Company Limited
  • Eisai Co. Ltd.
  • Ipsen SA
  • Mallinckrodt Pharmaceuticals Ltd.
  • Mylan N.V.
  • Sun Pharmaceutical Industries Ltd.
  • Wockhardt Ltd.
  • Zydus Lifesciences Limited

Methodology

Loading
LOADING...